09057220 News Today

Bio-Rad Laboratories, Inc. (NYSE:BIO – Get Free Report) has been given a consensus rating of “Moderate Buy” by the five ratings firms that are covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 1-year target […]

Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO – Get Free Report) have received an average recommendation of “Moderate Buy” from the five brokerages that are currently covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 1 […]

Bio-Rad Laboratories (NYSE:BIO – Get Free Report) will announce its earnings results after the market closes on Tuesday, May 7th. Analysts expect the company to announce earnings of $2.04 per share for the quarter. Parties interested in listening to the company’s conference call can do so using this link. Bio-Rad Laboratories (NYSE:BIO – Get Free […]

IFM Investors Pty Ltd bought a new stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm bought 4,057 shares of the medical research company’s stock, valued at approximately $1,403,000. Other hedge funds and other […]

StockNews.com upgraded shares of Bio-Rad Laboratories (NYSE:BIO – Free Report) from a hold rating to a buy rating in a report published on Thursday morning. Several other research firms also recently issued reports on BIO. Citigroup downgraded shares of Bio-Rad Laboratories from a buy rating to a neutral rating and dropped their price target for […]

Federated Hermes Inc. increased its position in Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) by 28.8% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 79,490 shares of the medical research company’s stock after acquiring an additional 17,762 shares during the quarter. Federated Hermes Inc.’s […]

Kornitzer Capital Management Inc. KS lowered its stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) by 9.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 36,647 shares of the medical research company’s stock after selling […]

Allspring Global Investments Holdings LLC increased its stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) by 11.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 166,127 shares of the medical research company’s stock after purchasing an […]

Bio-Rad Laboratories, Inc. (NYSE:BIO – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the five brokerages that are currently covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a hold rating and four have given a buy rating to the company. The average 1-year price target […]

Bio-Rad Laboratories (NYSE:BIO – Get Free Report) was downgraded by Citigroup from a “buy” rating to a “neutral” rating in a research note issued to investors on Wednesday, Marketbeat.com reports. They presently have a $365.00 target price on the medical research company’s stock, down from their previous target price of $400.00. Citigroup’s price target would […]